We propose a Built-In Self-Test (BIST) paradigm for analog and mixed-signal (A/M-S) Integrated Circuits (ICs), called symmetry-based BIST (SymBIST). SymBIST exploits inherent symmetries in an A/M-S IC to construct signals that are invariant by default, and subsequently checks those signals against a tolerance window. Violation of invariant properties points to the occurrence of a defect or abnormal operation. SymBIST is designed to serve as a functional safety mechanism. It is reusable ranging from post-manufacturing test, where it targets defect detection, to on-line test in the field of operation, where it targets low-latency detection of transient failures and degradation due to aging. We demonstrate SymBIST on a Successive Approximation Register (SAR) Analog-to-Digital Converter (ADC). SymBIST features high defect coverage, short test time, low overhead, zero performance penalty, and has a fully digital interface making it compatible with modern digital test access mechanisms. Index Terms-Analog and mixed-signal integrated circuit testing, built-in self-test, design-for-test, defect-oriented test, defect simulation, on-line test, concurrent error detection.
In this paper, we propose a defect-oriented Built-In Self-Test (BIST) paradigm for analog and mixed-signal (A/M-S) Integrated Circuits (ICs), called symmetry-based BIST (Sym-BIST). SymBIST exploits inherent symmetries into the design to generate invariances that should hold true only in defectfree operation. Violation of any of these invariances points to defect detection. We demonstrate SymBIST on a 65nm 10bit Successive Approximation Register (SAR) Analog-to-Digital Converter (ADC) IP by ST Microelectronics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.